National variations within the timings of transport to paediatric intensive care from 2018 to 2022: a cohort study

Scarlet-Daisy Prior1, Christopher Leahy2, Michael J Griksaitis3,4

  • 1University of Leeds, Leeds, UK scarlet-daisy.prior@nhs.net.

Insights

Paediatric Critical Care Transport (PCCT) services in the UK and Ireland show significant timing variations. Delays in PCCT mobilization may indicate operational or resource challenges impacting patient access to intensive care.

Area of Science:

  • Pediatric critical care medicine
  • Emergency medical services
  • Healthcare access and disparities

Background:

  • Paediatric Critical Care Transport (PCCT) services are vital for transferring critically ill children to specialized care.
  • Significant regional variations in PCCT timings across the UK and Ireland are suspected but not well-documented.

Purpose of the Study:

  • To describe and compare Paediatric Critical Care Transport (PCCT) timings across different regions in the UK and Ireland.
  • To identify potential challenges and disparities in access to pediatric intensive care units (PICUs).

Main Methods:

  • Retrospective cohort study utilizing data from the Paediatric Intensive Care Audit Network.
  • Analysis of emergency transports for children under 16 requiring PICU admission between January 2018 and December 2022.
  • Examination of transport incidence and time metrics, including team mobilization and bedside arrival.

Main Results:

  • Over 20,000 transports were analyzed, with over 40% conducted by services in London and Southeast England.
  • PCCT services in England were the only ones to achieve a median mobilization time under 30 minutes.
  • Nearly 25% of transports in Scotland, Southwest England, South Wales, and Ireland exceeded 3 hours to reach the bedside.

Conclusions:

  • This study is the first to compare PCCT service timings across the UK and Ireland, revealing significant regional differences.
  • Delays in PCCT mobilization highlight potential operational or resource limitations affecting equitable access to critical care.
  • Further investigation into these disparities is warranted to improve patient outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...